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Figure 1. Classification of Illness
A Quality Improvement Initiative Using A Novel Travel Survey to Define High-Risk 
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Introduction
In 2011, as reported by the World Tourism Organization, 980 million 
travelers crossed an international border (1).  As recently reported 
by the Global TravEpiNet, up to 59% of selected travelers have an 
underlying medical condition and many immunocompromised patients 
are traveling to developing countries (2).  Previous studies have 
documented that 20-64% of international travelers will develop some 
health problem while abroad (3).
Results
•	  Illness was reported in 104 (20%) of all responders (Table 1).
•	  Of those who reported illness, the most common were 
gastrointestinal-related 74 (14%) and respiratory illness 14 (3%) 
(Figure 1).
•	  The regions with the highest incidence of reported illness were 
South American and India with 27% and 22%, respectively. 
•	  Of the 104 travelers who reported illness, 28 (27%) sought medical 
attention while abroad.
Data collection demonstrated an 18% survey return rate
These illness rates were consistent with previously published data
Abstract
BACKGROUND -  We sought to define high-risk travel destinations 
and identify predictors of higher risk travel so that we can provide 
itinerary-specific care to our travelers.  We also sought to develop 
our post-travel survey as a valuable tool in gathering high quality, 
quantitative data as a quality improvement initiative
METHODS -  Post-travel surveys were mailed, and upon receipt 
de-identified data from travelers were entered into a database.  
Itinerary data, including continents and countries visited, illness 
encountered while abroad, and incidence of traveler’s diarrhea (TD) 
were the primary variables examined.  We performed a retrospective 
observational cohort analysis of patients from data collected in the 
post-travel survey.  Statistical analysis was performed using t-tests 
for continuous variables and chi-square and Fischer’s exact tests for 
categorical data.
RESULTS -  We mailed 2920 surveys to patients within one 
month of the date of their departure.  Of these surveys, 525 were 
returned (response rate of 18%) and responses entered into the 
database. The majority of respondents traveled to Asia (22%), or 
Africa (31%).  The mean number of travel days was 21.3 ± 72.5, 
the median 14.  Univariate analysis demonstrated a statistically 
significant risk of general illness for travel greater than 14 days (27.7% 
vs.  11.3%, p<0.001).  Duration of travel was also significant with 
regard to development of TD (p=0.0015).  Destination of travel and 
development of TD trended toward significance, but did not meet 
it.  Serious illness requiring travelers to see a local physician was 
infrequent, as were vaccine-related complications.
CONCLUSION -  The data observed, including rates of illness, were 
consistent with previously published travel medicine literature.  The 
post-travel survey has been modified as a result of our cohort study, 
and has been expanded to identify specific variables, including patient 
co-morbidities, reason for travel, and accommodations.  A limitation 
of this study was the low rate of return of the post-travel survey.  To 
improve survey response rate, we plan to add additional modalities for 
the survey, including E-mail reminders and a web-based database. 
Figure 2. Frequency of TD by Duration of Travel
Figure 3. Percentage of Travelers Developing Travelers Diarrhea (TD) 
by Duration of Travel
Figure 4. Satisfaction with Pre-travel Advice
Study Benefits
•	  Post-travel survey has demonstrated value as a QI tool; data 
collected will guide pre-travel visit counseling
•	  Knowledge of illnesses particular to regions will ensure travel-specific 
care
•	  Significance of TD development prompted discussion on prescribing 
prophylactic antibiotics
Study Limitations
•	  Low survey return rate (18%) may have led to sampling error
•	  Survey responses may have been subject to a recall bias
Discussion
•	  Expansion of demographic data collection (age, medical 
comorbidities, itinerary details) will allow for more detailed instructions 
about travel risks and precautions
•	  Email or web-based collection will be used to improve return rate
Future Direction
•	  Travelers in this study did not have a statistically significant difference 
in acquiring illness for different travel destinations, though duration of 
travel was strongly significant for developing illness, notably TD.
•	  Rates of illness was consistent with previously published travel data, 
though the travelers in our study sought medical attention abroad at 
a higher rate than predicted by prior studies (4,5). 
•	  Capturing pre- and post-travel data using this novel travel survey 
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("n" equals total travelers per time interval)
* Some travelers did not report TD as “illness”
Table I. Travel Characteristics
Destination Number of Travelers Travelers Reporting Illness Traveler’s Diarrhea*
Asia 117 (22%) 25 (21%) 25 (21%)
South America 99 (19%) 27 (27%) 28 (28%)
Africa 161 (31%) 28 (17%) 43 (27%)
Europe 13 (2%) 0 (0%) 0 (0%)
Central America 74 (14%) 12 (16%) 13 (18%)
Australia 5 (1%) 0 (0%) 0 (0%)
India 46 (9%) 10 (22%) 8 (17%)
Multiple Continents 10 (2%) 2 (20%) 3 (30%)
TOTAL 525 (100%) 104 (20%) 120 (23%)
340, (65)
141(27)
35 (7) 5 (1)
Figure 4. S atis faction w ith P re -trave l A dv ice
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(Number in Parentheses represents the percentage of total responding travelers)
